$AMBA, $DG, $SMAR, $ULTA, $ZYME
Below is a list of stocks analysts have singled out to look at carefully Tuesday, as follows:
Ambarella Inc. (NASDAQ:AMBA) Morgan Stanley reiterated it as Overweight and raised the target price to 60 from 52. Cowen reiterated it as Outperform and raised the target price to 68 from 54.
Dollar General Corp. (NYSE:DG) Morgan Stanley reiterated its Overweight rating and raised the target price to 155 from 142, and Barclays reiterated its Overweight rating and raised its target to 180 from 141. Piper Jaffray reiterated its Overweight rating and raised its target to 170 from 137.
Smartsheet Inc. (NYSE:SMAR) was reiterated as Outperform with a 62 target price at Wedbush.
Ulta Beauty Inc. (NASDAQ:ULTA) UBS maintained its Buy rating but cut the target to 300 from 365, Cowen maintained its Outperform rating but cut its target to 313 from 375. Wells Fargo downgraded it to Market Perform from Outperform.
Zymeworks Inc. (NYSE:ZYME) was started with a Buy rating and assigned a 45 target price at Stifel. The stock has a 52-wk trading range of 10.72 to 27.19 and a consensus target price of 24.88.
Have a terrific week
Latest posts by HEFFX Australia (see all)
- Euro: USD/EUR (EUR=X) Some dollar volatility - May 25, 2020
- Thailand Baht: USD/THB (THB) Exports Rose, No New COVID-19 Cases - May 24, 2020
- Triple Crown and other major stakes for 3-year-olds finally firming up - May 22, 2020